In diabetic patients, compliance to diet therapy has been an ongoing concern. We thus examined the effects of an aspartame-and acesulfame K-containing sweetener (PZ) on postprandial hyperglycemia in mild and borderline diabetics. In two sets of crossover, randomized, placebo-controlled, double-blind tests, subjects with mild or borderline diabetes were challenged with meals consisting of white rice, and 
Introduction
The basic treatment for diabetes is diet therapy (Eriksson and Lindgärde, 1998; Heilbronn et al., 1999; Kurose and Seino, 2006) . The objective of diet therapy is to restrict energy intake, particularly sugar, to reduce body weight (if patient is overweight), and to control blood glucose levels. There are several functional foods that are known to be useful in helping to achieve these objectives: indigestible dextrin (Sioda et al., 2001) , polyphenols from guava tea (Deguchi, et al., 2000) , and salacia oblonga (Williams et al., 2007) , all of which reduce the rate of sugar absorption and help control blood glucose levels.
Alternatively, sugar substitutes that have sweetness many times that of sucrose (common table sugar) can limit energy intake without compromising the taste enjoyed in a variety of diets. At present, there are several artificial and natural high-intensity sweeteners widely used in different blends, among which aspartame, acesulfame potassium (acesulfame K), and erythritol are the most popular. Aspartame (N-(L-α-Aspartyl)-L-phenylalanine, 1-methyl ester), a methyl ester of the dipeptide of the natural amino acids aspartic acid and phenylalanine, is an artificial sweetener that has been used worldwide in over 120 countries in the past 25 years. Acesulfame K (potassium 6-methyl-2,2-dioxo-oxathiazin-4-olate) is an energy-free artificial sweetener derived from acetic acid that is metabolized minimally in the body. Although both aspartame and acesulfame K have a sweetness of about 200 times that of sugar (Cloninger and Baldwin, 1974) , no rise in blood glucose concentration results from the consumption of 500 mg of aspartame (Okuno et al., 1986) or from 2.56 g of acesulfame K (Liang et al., 1987) . Erythritol (2R,3S)-butane-1,2,3,4-tetraol) is a natural sugar alcohol, which has a sweetness of about 0.75 times that of sugar, and is absorbed in the small intestine and excreted unmetabolized in the urine, and similarly, oral intake of 20 g does not cause a rise in blood ods of the study from a physician, and gave written informed consent.
Subjects were instructed not to alter their lifestyle habits, such as their diet, amount of smoking, and exercise during the test period. Excessive amounts of drinking, eating, and exercise were prohibited. Subjects were also given restrictions on their intake of products other than the test meal (such as functional foods) that have effects of lowering blood glucose.
Study design The study was a randomized, double-blind trial comprising two sets of crossover meal challenge tests. A flowchart of the study is shown in Figure 1 . During the study period, subjects were required to visit the hospital four times (testing days 1, 2, 3 and 4). They arrived at the hospital and started the meal challenge test at the same time in the morning for each testing day. The meal challenge test on testing days 1 and 3 was referred to as Study 1, and that on testing days 2 and 4 was referred to as Study 2. There was a washout period of two weeks between each testing day.
Test meals The test meal for Study 1 ("PZ meal") consisted of 100 g of white rice, and two side dishes flavored using PZ (Ajinomoto Co., Inc., Tokyo, Japan); the control meal for Study 1 ("Control meal") consisted of 100 g of white rice, and two side dishes flavored using sugar. The test meal for Study 2 ("PZ sweets") consisted of sweet red bean soup ("oshiruko") flavored with PZ; the control meal for Study 2 ("Control sweets") consisted of sweet red bean soup flavored with sugar. The menus for Study 1 and Study 2 are shown in Table 1 , and the nutritional contents of the meals are shown in Table 2 . The amount of PZ used was determined so as to obtain an equivalent level of sweetness as the Control meal and Control sweets. Before commencement of the study, the IRB confirmed that the PZ meal or PZ sweets were indistinguishable from their control meals by appearance or their containers (Study 1, plastic containers; Study 2, paper cups), or by sensory stimulation such as taste. The test meals were selected based on common Japanese meals (white rice and boiled food) and sweets.
Meal challenge test The meal challenge test was conducted on subjects who had fasted for 10 h or more after their dinner the night before in order to eliminate the effects of previous meals on the results.
On testing days 1 and 3, subjects were made to consume PZ or Control meal in 15 min (Study 1). On testing days 2 and 4, subjects were made to consume PZ or Control sweets in 3 min (Study 2). On both testing days, subjects were made to drink 150 mL of water immediately after consumption of their meal, and an additional 100 mL of water after their blood was collected at two hours postprandially.
Blood was collected six times, once before the meal chalglucose concentration (Ishikawa et al., 1996) . However, to date, there have been no studies evaluating the effects of these sweeteners in daily meals on postprandial blood glucose levels. Pal Sweet Calorie Zero ® ("PZ"), which is widely used in Japan, is a low-energy high-intensity sweetener (three times sweeter than glucose) based on aspartame (0.58%) and blended with acesulfame K (0.25%) and erythritol (98.98%). Inoue and Murakami previously conducted a crossover test involving mild diabetics and pre-diabetics, in which subjects were challenged with 37.5 g of glucose or 9 g of PZ with equivalent sweetness, and have reported that the rise in their blood glucose levels were significantly lower after challenge with PZ, as compared with glucose (Inoue and Murakami, 2005) . This report suggests the possibility that substitution of sugar with PZ will enable diabetics to enjoy sweetness while limiting sugar intake. Due to the superior heat stability of PZ, meals cooked using PZ as a substitute sweetener may be useful for diabetic diet therapy. We therefore conducted a randomized, double-blind, placebocontrolled, single-dose, crossover study in order to evaluate the effects of PZ, used as a sweetener for meals or sweets, on postprandial rises in blood glucose in mild and borderline diabetics.
Material and Methods
Subjects Subjects were selected from a database of previously untreated adults, aged 20 to 65 years, at Soiken Inc. The inclusion criterion was fasting blood glucose concentration of 110 mg/dL or above and under 140 mg/dL, in the three months prior to commencement of the study. Subjects were excluded if they were receiving treatment for diabetes, were participating in other clinical trials, were pregnant, possibly pregnant or nursing, possibly allergic to the test food, donated blood (200 mL or more within a month, or 400 mL or more within three months) or had phenylketonuria, serious liver, cardiovascular, respiratory, endocrine, or metabolic disorders. The 38 subjects that met the above selection criteria were randomized into two groups, and baseline values for age, sex, body mass index (BMI), blood glucose, insulin, and HbA1c were confirmed to be similar in the two groups (p > 0.2).
The study was approved by the joint institutional review board (IRB) of Soiken Inc. and Soiken Clinic, and was conducted in accordance with the Declaration of Helsinki (as adopted in 1964, revised in '75, '83, '89, '96, 2000, annotation added in 2002, '04) 
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Results
Population analysis Figure 1 shows a flowchart of the study population at each stage. Among the 38 subjects enrolled in the study, 3 subjects withdrew in the period between group allocation and testing day 1 for personal reasons unrelated to the study, and one subject withdrew between testing day 1 and testing day 4; a total of 34 subjects completed the study. Among the 34 subjects, 7 subjects smoked regularly and all of them smoked more than 10 cigarettes a day. Moreover, 13 subjects regularly consumed alcohol once or more a week and 4 of them consumed more than 60 g of alcohol per day. After study completion and before unblinding, all data for one subject who failed to completely consume the test meal in Study 1, and insulin data for two subjects due to hemolysis of the samples, were excluded from the efficacy analysis for Study 1. Similarly, all data for one subject who suffered from severe symptoms of a cold, and for two subjects in whom there were large differences in fasting (prechallenge) triglyceride or blood glucose levels between the two test days in Study 2, presumably due to alcohol intake on the previous day, were excluded. As a result, the total number of subjects included in the efficacy analysis was 33 (23 males, 10 females) in Study 1, and 31 (21 males, 10 females) in Study 2. The baseline characteristics of the subjects included in the efficacy analyses in Studies 1 and 2 are shown in Table 3 (a) and (b), respectively. There were no significant differences in sex, age, height, body weight, BMI, blood glucose, insulin, or HbA1c between the two study groups. lenge test and five times afterwards (0.5, 1, 1.5, 2 and 3 h postprandially). Laboratory tests were performed for blood glucose, insulin, triglycerides, free fatty acids and C-peptides.
Blood analyses were conducted by the Kishimoto Medical Science Laboratory Osaka (Osaka, Japan) using standard methods.
Questionnaire on taste A questionnaire on taste was conducted for each side dish in Study 1 and the sweet red bean soup in Study 2. In both studies, the subjects recorded: whether they thought it contained PZ (choice of YES/NO); and the palatability and sweetness they felt at the time of consumption of the meals using a visual analogue scale (VAS).
Statistical analysis All data were calculated as means ± standard deviation. The area under the blood concentrationtime curve (AUC) was calculated by the trapezoidal method from before the meal to three hours postprandially. Statistical analyses were conducted for all test parameters in Studies 1 and 2. Differences between each of the meal challenge tests were compared using the paired Student's t-test. Interactions between time and meals were analyzed using two-way analysis of variance (ANOVA).
Data were processed using the software package SPSS ver.11.5 (SPSS Japan, Inc. Tokyo, Japan). All statistical tests were two-tailed. p values of less than 0.05 were considered to indicate statistical significance. p values of less than 0.1 were noted as indicating a general tendency.
Aspartame-Acesulfame K-sweetener Effect Consumption of the PZ meal gave the following significant differences and tendencies in comparison with the Control meal: blood glucose was significantly lower at 0.5, 1 and 1.5 hours postprandially (p < 0.001, p < 0.001, p < 0.01, respectively). Insulin was significantly lower at all postprandial measurement points (p < 0.01, p < 0.001, p < 0.001, p < 0.001, p < 0.001, respectively). Triglycerides tended to be lower at 1 hour postprandially (p < 0.1). Free fatty acids were significantly higher at 1.5, 2, and 3 hours postprandially
The safety analysis included all 35 subjects who participated from testing day 1.
Efficacy analysis a) Study 1 Changes in blood glucose, insulin, triglycerides, free fatty acids and C-peptides in the meal challenge tests are shown in Figure 2 . On ANOVA, we found a significant difference between the PZ and Control meal groups in the pattern of changes in all data, except that of triglycerides (all, p < 0.001). Statistical significance between meal groups is indicated as follows: +p < 0.1, *p < 0.05, **p < 0.01, or ***p < 0.001. free fatty acids, on the other hand, tended to be higher after the PZ meal (1.336 ± 0.416 vs. 1.264 ± 0.380 mEq·h/L; p < 0.1).
b) Study 2 Changes in blood glucose, insulin, triglycerides, free fatty acids, and C-peptides during the meal challenge test are shown in Figure 3 . On ANOVA, we found, as in Study 1, a significant difference between the PZ and Control sweet groups in the pattern of changes in all parameters, except for triglycerides (all p < 0.001).
(p < 0.05, p < 0.01, p < 0.001, respectively). C-peptides were significantly lower or tended to be lower at all postprandial measurement points (p < 0.1, p < 0.001, p < 0.001, p < 0.01, p < 0.01, respectively).
The AUC values after the PZ meal were significantly lower than after the Control meal for blood glucose (470.9 ± 61.4 vs. 517.0 ± 82.6 mg·h/dL; p < 0.001), insulin (54.03 ± 21.66 vs. 78.29 ± 35.11 μU·h/mL; p < 0.001) and C-peptides (9.07 ± 1.99 vs. 10.86 ± 2.93 ng·h/mL; p < 0.001). Those for Aspartame-Acesulfame K-sweetener Effect -0.5 0 0.5 1 1.5 2 2.5 3 Time (h) C-Peptides (ng/mL) *** *** *** *** (e) *** the efficacy of PZ as a sugar substitute use in daily meals and sweets. In particular, detailed observation of the test results in Study 2 revealed that the consumption of PZ sweets caused almost no changes in blood glucose, while consumption of Control sweets with high sugar intake caused a peak response in blood glucose at 1 h postprandially, followed by a rapid decline in blood glucose at 3 h postprandially. After consumption of Control sweets, it is believed that insulin, which transiently rises in response to the meal challenge test, causes blood glucose levels to fall below baseline levels after the digestion and absorption of the food is almost complete. It has been previously reported that reactive hypoglycemia, characterized by lower blood glucose levels when compared with preprandial levels, often occurs three to four hours postprandially in mild diabetic and borderline subjects, the study population of the present study (Brun et al., 2000) . However, in the present study, no hypoglycemic events were noted at 3 h following the meal challenge test in the PZ group, thus suggesting that the substitution of PZ for sugar is effective at preventing reactive hypoglycemia. Substantiating the above results for blood glucose levels, significantly lower values in insulin and C-peptide levels were noted for the PZ group as compared with those in Control group at each postprandial measurement point and in AUC. The lower insulin values noted in PZ group were considered to be attributable to the suppression of the rise in blood glucose, leading to weaker stimuli to secrete insulin. For free fatty acids, significantly higher values were noted in the PZ group, particularly for PZ sweets, as compared with Control group at postprandial measurement points and in AUC. The cellular uptake of free fatty acids, as well as that of glucose, is induced by insulin (Chen et al., 1987) . It is possible that because consumption of PZ meal and sweets resulted in lower insulin values when compared to consumption of Control meal and sweets, the cellular uptake of free fatty acids was reduced, leading to significantly higher values. Triglyceride, on the other hand, tended to be lower postprandially in the PZ group, as compared with that in the Control group. This tendency may be attributed to less metabolized carbohydrates being absorbed in the consumption of PZ meal and sweets as compared with that of Controls, leading to the suppression of carbohydrate-induced hepatic VLDL synthesis.
These results indicate two potentially beneficial effects of substituting sugar with PZ while all other ingredients are the same in meals or sweets (such as sweet red bean soup); it can suppress postprandial rises in blood glucose levels, and it can reduce energy intake without any obvious changes in sweetness or taste. Erythritol is known to make aspartame taste more similar to sugar, and because PZ is highly adaptable in Consumption of PZ sweets gave the following significant differences and trends in comparison with the Control sweets. Blood glucose was significantly lower at 0.5, 1, 1.5, and 2 hours postprandially (p < 0.001, p < 0.001, p < 0.001, and p < 0.05, respectively), but was significantly higher at 3 hours postprandially (p < 0.001). On the other hand, similarly to Study 1, insulin was significantly lower at all postprandial measurement points (all p < 0.001). Triglycerides tended to be lower at 3 h postprandially (p < 0.1). Free fatty acids were significantly higher at all postprandial measurement points (p < 0.01, p < 0.001, p < 0.001, p < 0.001, and p < 0.001, respectively). C-peptides were significantly lower at all postprandial measurement points (all p < 0.001).
Similarly to Study 1, AUC values after PZ sweets were significantly lower than after Control sweets for blood glucose (367.4 ± 29.3 vs. 469.6 ± 70.5 mg·h/dL; p < 0.001), insulin (30.58 ± 5.47 vs. 58.78 ± 22.22 μU·h/mL; p < 0.001), and C-peptides (5.90 ± 1.01 vs. 9.31 ± 1.97 ng·h/mL; p < 0.001). Those for free fatty acids, on the other hand, were significantly higher after PZ meal (2.008 ± 0.623 vs. 1.267 ± 0.484 mEq·h/L; p < 0.001).
Questionnaire on taste On the questionnaire on taste, approximately 40% of the subjects in Study 1, and approximately 60% of the subjects in Study 2 identified the use of PZ in their meal. No significant differences in sweetness and palatability were noted between the test and control meals in studies 1 and 2 (data not shown). Based on these results, the use of PZ as a substitute for sugar was considered to have no significant effect on palatability.
Safety evaluation Clinical evaluations within three days after consumption of the test meal revealed one subject in the Control meal group with nasal discharge, sneezing, general malaise, and itchiness in the conjunctiva; and one subject each in the Control meal and PZ sweet groups with cold-like symptoms. All clinical findings were unrelated to the test meals, as judged by a physician.
Discussion
In the present study, we used PZ to flavor regular meals (Study 1: PZ 11 g) or sweets (Study 2: PZ 17 g) and evaluated the effect of PZ on postprandial rises in blood glucose in subjects with mild or borderline diabetes.
The results of both Studies 1 and 2 revealed that in subjects who consumed PZ meal and sweets, significantly lower values for blood glucose and AUC occurred postprandially, as compared with subjects who consumed Control meal and sweets, respectively, thus confirming that PZ suppresses postprandial rises in blood glucose. These results were generally consistent with previous reports (Inoue and Murakami 2005) , but this is the first study that has successfully shown suppress the postprandial rise in blood glucose without significantly compromising palatability when used in diet therapy as a substitute sweetener for daily meals. In addition to the benefit of improving blood glucose control, PZ provides a chance for diabetic patients to enjoy desserts and sweets, such as sweet red bean soup, that contain high levels of sugars. If this leads to more variety in the menu items for the patients and improves their QOL, it may also lead to improved patient compliance to diet therapy.
cooking (Matsuda, 2005) and can be used in various recipes, it can be regarded as significantly useful.
It is thought that the recurrence of postprandial hyperglycemia results in glucose toxicity, one of the major factors responsible for the development and aggravation of type 2 diabetes (Yki-Järvinen, 1998; Kajimoto and Kaneto, 2004) . Considering the pathogenic mechanisms of postprandial hyperglycemia (Yki-Järvinen, 1998) , hyperglycemic levels and their duration are the two determining factors of severity. By fully or partially substituting PZ for sugar in some or all meals, partial suppression of postprandial hyperglycemia can be achieved. Thus by continuous partial use of PZ, the resulting medium-to long-term partial suppression of postprandial hyperglycemia may eventually improve glucose toxicity and contribute to the prevention of the onset or progression of diabetes.
With regard to energy intake, as PZ as a sugar substitute can reduce the energy content of sugar, we surmise that PZ would also be effective for body weight reduction in relatively overweight people. On the other hand, in normalto underweight people with no margin for weight loss, the frequent and continuous use of PZ may result in emaciation from lack of energy intake; in which case, it would be necessary to supplement the energy with other food accordingly. Further studies are required to verify the effectiveness and safety of medium-to long-term use of PZ in overweight, and normal-or underweight individuals using parameters such as body weight and HbA1c for evaluation.
In the present study, PZ was demonstrated to be effective in previously untreated mild or borderline diabetics, but it may also be potentially beneficial in improving postprandial hyperglycemia in diabetic patients who are undergoing treatment with insulin or oral anti-diabetic drugs. However, using PZ to limit glucose intake in such patients may cause hypoglycemia. Preventative measures against hypoglycemia in these patients should presumably be taken by gradually substituting PZ for sugar, while adjusting and reducing the amount of insulin or oral anti-diabetic drugs. Further studies are required to evaluate the effects of medium-to long-term use of PZ on blood glucose control in such diabetic patients undergoing treatment.
Moreover, as no adverse events related to the test meal were observed during the present study, and when the existing results of clinical and non-clinical studies on safety and practical eating experiences were considered regarding the major constituents (erythritol, aspartame and acesulfame K), the possibilities for diabetic patients to develop safetyrelated problems in the case of continuous consumption were presumed to be substantially limited.
In summary, the use of PZ was confirmed to markedly
